Has Tim Leier, MD received payments from drug or device companies?

Yes. Drug and device makers reported $449,014 in general payments to Tim Leier, MD across 1,066 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tim Leier, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tim Leier, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tim Leier, MD

Interventional Pain Medicine · Rancho Mirage, CANPI 1972777316

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $276,569 of the $449,014 with a category attached, or 61.6%. Boston Scientific accounts for 78.0% of it on its own, with 18 other manufacturers making up the rest. Among interventional pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$449,014in general payments, 2019–2025

Across 1,066 payments — averaging $421.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$350K
Curonix LLC$49K
Painteq LLC$24K
Medtronic$17K
Relievant Medsystems, Inc.$2K
Vertiflex, Inc.$2K
plus $6K from 13 others

$301,902in research payments, 2019–2025

Across 242 payments — averaging $1247.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$293K
Curonix LLC$6K
Nevro Corp.$2K
Saluda Medical Americas, Inc.$16

What the payments were for

Consulting fees$51,68812%
Speaking & faculty fees$276,56962%
Travel & lodging$72,70016%
Food & beverage$30,7067%
Education$17,1434%
Entertainment$2100%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	700	$350,030
Curonix LLC	75	$48,651
Painteq LLC	79	$23,766
Medtronic(2 entities)	101	$17,249
Relievant Medsystems, Inc.	10	$1,647
Vertiflex, Inc.	10	$1,505
Abbott	22	$1,326
SPR Therapeutics, Inc	10	$1,243
Spinal Simplicity, LLC	6	$1,036
Nevro Corp.	17	$895
Foundation Fusion Solutions, LLC	7	$456
AbbVie(2 entities)	16	$325
Si-bone, Inc.	4	$296
Bioness Inc	1	$180
Stryker	3	$136
MML US, Inc.	2	$125
Stimwave Technologies Incorporated	1	$93
Globus Medical	1	$43
Scilex Pharmaceuticals Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Superion Indirect Decompression System$77,607
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$46,879
WaveWriter Alpha Prime 16$42,980
GENERAL PAIN MANAGEMENT$41,639
GENERAL - THERAPIES$29,176
SPECTRA WAVEWRITER$27,796
SUPERION$25,882
PAINTEQ$21,714
WAVEWRITER ALPHA$20,558
INTELLIS ADAPTIVESTIM$13,777
Intracept$6,492
VERCISE$2,592
INTELLIS$1,422
Superion ISS$1,289
SPRINT PNS System$1,060
HA MINUTEMAN G3-R$954
Proclaim Family of SCS IPGs$837
Senza Spinal Cord Stimulation System$476
Stimrouter for pain$180
VANTA ADAPTIVESTIM$135

How this compares

$449,014 in reported general payments places this provider in the 95th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$28,008

Medicare patients

Services billed

202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	39	$854
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	21	$568
Gabapentin	42	$358
Naproxen	29	$325
Baclofen	39	$256
Oxycodone Hcl	12	$185
Duloxetine Hcl	16	$164
Cyclobenzaprine Hcl	12	$88
Cephalexin	18	$51
Meloxicam	27	$42

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Rancho Mirage

Andrew GermanovichRancho Mirage$333K
Yamin SallowmRancho Mirage$16K
Michael Verdolinla Mesa$507K
Jonathan GrossmanVisalia$404K
Kasra MaasumiRancho Santa Margarita$388K
David LeeYorba Linda$257K
Standiford HelmOrange$254K
Patrick BuchananCamarillo$219K
Chau VuSanta Rosa$141K
Phillip LimBuena Park$127K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →